The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon India Mutual Fund
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nippon India Mutual Fund, acting through Nippon Life India Trustee Ltd, has disclosed a purchase of 44,00,000 shares (3.16% stake) of HealthCare Global Enterprises Ltd via open market transactions. The purchases were spread over a long period from March 31, 2016 to September 10, 2025. Following this acquisition, Nippon India Mutual Fund's total holding in HCG stands at 79,00,000 shares, representing 5.67% of the company's share capital. The acquirer is not part of the promoter or promoter group of HCG.
This is a passive institutional investor (mutual fund) increasing its stake in HCG through open market buying, which is generally viewed as a confidence signal. However, the holding remains below the 10% SAST trigger threshold, so no mandatory open offer is required. Shareholders may see this as a positive institutional endorsement, but it has limited direct price impact.